Citadel Advisors’s Moolec Science SA Warrant MLECW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-52,797
Closed -$243 13735
2025
Q4
$243 Buy
52,797
+300
+0.6% +$4 ﹤0.01% 12506
2025
Q3
$766 Sell
52,497
-600
-1% -$9 ﹤0.01% 12605
2025
Q2
$796 Sell
53,097
-2,064
-4% -$29 ﹤0.01% 12272
2025
Q1
$458 Sell
55,161
-200
-0.4% -$6 ﹤0.01% 14258
2024
Q4
$1.41K Sell
55,361
-5,156
-9% -$204 ﹤0.01% 14193
2024
Q3
$2.42K Buy
60,517
+174
+0.3% +$9 ﹤0.01% 13752
2024
Q2
$3.62K Sell
60,343
-2,215
-4% -$129 ﹤0.01% 13574
2024
Q1
$3.09K Buy
+62,558
New +$2.53K ﹤0.01% 13946
2023
Q3
Sell
-15,404
Closed -$1.23K 14782
2023
Q2
$1.23K Buy
15,404
+533
+4% +$46 ﹤0.01% 13959
2023
Q1
$1.67K Buy
+14,871
New +$2.15K ﹤0.01% 14258

Other funds holding MLECW

Citadel Advisors's MLECW Position: Q1 2026 in Review

Citadel Advisors sold out of Moolec Science SA Warrant (MLECW) in Q1 2026, closing a stake of 52,797 shares — an estimated $243 sold.

Citadel Advisors first reported a position in MLECW in Q1 2023 and held it in 10 quarters. The position peaked at $3.62K in Q2 2024. 15 funds tracked by Wall St. Rank hold MLECW as of Q1 2026.

  • Citadel Advisors reported no remaining Moolec Science SA Warrant position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 52,797 Moolec Science SA Warrant shares in Q1 2026, an estimated $243.
  • Citadel Advisors first reported a position in Moolec Science SA Warrant in Q1 2023 and held it in 10 quarters.
  • Citadel Advisors's Moolec Science SA Warrant position peaked at $3.62K in Q2 2024.
  • 15 funds tracked by Wall St. Rank held Moolec Science SA Warrant as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.